Targeting MicroRNAs to withstand cancer metastasis

Methods in Molecular Biology

Volumn 1218, Issue , 2015, Pages 415-437

  Profumo, Valentina ^a   Doldi, Valentina ^a   Gandellini, Paolo ^a   Zaffaroni, Nadia ^a  

^a NONE

Author keywords

Cancer metastasis; MicroRNA; MiRNA inhibitors; MiRNA mimics; MiRNA based therapeutics

Indexed keywords

MICRORNA; MICRORNA 10B; MICRORNA 122; MICRORNA 126; MICRORNA 132; MICRORNA 145; MICRORNA 15A; MICRORNA 16; MICRORNA 200; MICRORNA 200C; MICRORNA 205; MICRORNA 221; MICRORNA 222; MICRORNA 223; MICRORNA 31; MICRORNA 9;

ANGIOGENESIS; ANOIKIS; ARTICLE; BONE METASTASIS; BREAST METASTASIS; CELL MIGRATION; CHRONIC LYMPHATIC LEUKEMIA; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; INFLAMMATION; LUNG METASTASIS; METASTASIS; NONHUMAN; PRIORITY JOURNAL; TUMOR MICROENVIRONMENT;

EID: 84921883470     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1538-5_25     Document Type: Article

References (92)

1. Profumo V, Gandellini P (2013) MicroRNAs: cobblestones on the road to cancer metastasis. Crit Rev Oncog 18:341–355
2. Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331: 1559–1564
3. Esteller M (2011) Non-coding RNAs in human disease. Nat Rev Genet 12:861–874
4. Pasquinelli AE (2012) MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 13:271–282
5. Winter J, Jung S, Keller S et al (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11: 228–234
6. Yi R, Qin Y, Macara IG et al (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17: 3011–3016
7. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281–297
8. Place RF, Li LC, Pookot D et al (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A 105:1608–1613
9. Reinhart BJ, Weinstein EG, Rhoades MW et al (2002) MicroRNAs in plants. Genes Dev 16: 1616–1626
10. Guo H, Ingolia NT, Weissman JS et al (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835–840
11. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215–233
12. Ambros V (2003) MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113:673–676
13. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5:522–531
14. Iorio MV, Croce CM (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4:143–159
15. Fiorucci G, Chiantore MV, Mangino G et al (2012) Cancer regulator microRNA: potential relevance in diagnosis, prognosis and treatment of cancer. Curr Med Chem 19:461–474
16. Aigner A (2011) MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs. J Mol Med 89:445–457
17. Cho WC (2010) MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets therapy. Int J Biochem Cell Biol 42: 1273–1281
18. Calin GA, Dumitru CD, Shimizu M et al (2002) Frequent deletions and down- regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99:15524–15529
19. Cimmino A, Calin GA, Fabbri M et al (2006) miR-15 and miR-16 induce apoptosis by targeting BCL 2. Proc Natl Acad Sci U S A 102:13944–13949
20. Hay ED (2005) The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 233: 706–720
21. Acloque H, Thiery JP, Nieto MA (2008) The physiology and pathology of the EMT. Meeting on the epithelial-mesenchymal transition. EMBO Rep 9:322–326
22. Lee JM, Dedhar S, Kalluri R et al (2006) The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172:973–981
23. Miska EA (2008) MicroRNAs—keeping cells in formation. Nat Cell Biol 10:501–502
24. Gregory PA, Bert AG, Paterson EL et al (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP 1. Nat Cell Biol 10: 593–601
25. Park SM, Gaur AB, Lengyel E et al (2009) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB 2. Genes Dev 22:894–907
26. Gandellini P, Folini M, Longoni N et al (2009) MiR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res 69: 2287–2295
27. Burk U, Schubert J, Wellner U et al (2008) A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9:582–589
28. Bracken CP, Gregory PA, Kolesnikoff N et al (2008) A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 68:7846–7854
29. Ueno K, Hirata H, Shahryari V et al (2011) Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma. Br J Cancer 104:308–315
30. Valastyan S, Reinhardt F, Benaich N et al (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137:1032–1046
31. Ma L, Teruya-Feldstein J, Weinberg RA et al (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449:682–688
32. Bissell MJ, Hines WC (2011) Why don’t we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 17:320–329
33. Wentz-Hunter KK, Potashkin JA (2011) The role of miRNAs as key regulators in the neoplastic microenvironment. Mol Biol Int 2011: 839872
34. Bissell MJ, Radisky D (2001) Putting tumours in context. Nat Rev Cancer 1:46–54
35. Liu X, Yu J, Jiang L et al (2009) MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. Cancer Genomics Proteomics 6:131–139
36. Garofalo M, Di Leva G, Romano G et al (2009) miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16:498–509
37. Gandellini P, Profumo V, Folini M et al (2011) MicroRNAs as new therapeutic targets and tools in cancer. Expert Opin Ther Targets 15: 265–279
38. Folini M, Gandellini P, Longoni N et al (2010) miR-21: an oncomir on strike in prostate cancer. Mol Cancer 9:12
39. LeBleu VS, Macdonald B, Kalluri R (2007) Structure and function of basement membranes. Exp Biol Med 232:1121–1129
40. Gandellini P, Profumo V, Casamichele A et al (2012) miR-205 regulates basement membrane deposition in human prostate: implications for cancer development. Cell Death Differ 19: 1750–1760
41. Kundu JK, Surh YJ (2012) Emerging avenues linking inflammation and cancer. Free Radic Biol Med 52:2013–2037
42. Trinchieri G (2012) Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol 30:677–706
43. Mayr C, Hemann MT, Bartel DP (2007) Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315:1576–1579
44. Johnson SM, Grosshans H, Shingara J et al (2005) RAS is regulated by the let-7 microRNA family. Cell 120:635–647
45. Iliopoulos D, Hirsch HA, Struhl K (2009) An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139: 693–706
46. Iliopoulos D, Jaeger SA, Hirsch HA et al (2010) STAT3 activation of miR-21 and miR-181b- 1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 39:493–506
47. Gandellini P, Giannoni E, Casamichele A et al (2013) miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts. Antioxid Redox Signal. 20:1045–1059
48. Majid S, Dar AA, Saini S et al (2010) MicroRNA- 205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer 116:5637–5649
49. Aprelikova O, Yu X, Palla J et al (2010) The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle 9: 4387–4398
50. Musumeci M, Coppola V, Addario A et al (2011) Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Oncogene 30:4231–4242
51. Bronisz A, Godlewski J, Wallace JA et al (2011) Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol 14:159–167
52. Stacker SA, Achen MG, Jussila L et al (2002) Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2:573–583
53. Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3:401–410
54. Dews M, Fox JL, Hultine S et al (2010) The myc-miR-17 ~ 92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}- dependent antiangiogenic factors. Cancer Res 70:8233–8246
55. Anand S, Majeti BK, Acevedo LM et al (2010) MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat Med 16:909–914
56. Rennebeck G, Martelli M, Kyprianou N (2005) Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis? Cancer Res 65:11230–11235
57. Howe EN, Cochrane DR, Richer JK (2011) Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res 13:R45
58. Formosa A, Lena AM, Markert EK (2012) DNA methylation silences miR-132 in prostate cancer. Oncogene. doi: 10.1038/onc.2012.14
59. Png KJ, Yoshida M, Zhang XH et al (2011) MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev 25:226–231
60. Tavazoie SF, Alarcón C, Oskarsson T et al (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147–152
61. Fenderico N, Casamichele A, Profumo V et al (2013) MicroRNA-mediated control of prostate cancer metastasis: implications for the identification of novel biomarkers and therapeutic targets. Curr Med Chem 20:1566–1584
62. Hutvágner G, Simard MJ, Mello CC et al (2004) Sequence-specific inhibition of small RNA function. PLoS Biol 2:E98
63. Meister G, Landthaler M, Dorsett Y et al (2004) Sequence-specific inhibition of microRNAand siRNA-induced RNA silencing. RNA 10: 544–550
64. Krützfeldt J, Rajewsky N, Braich R et al (2005) Silencing of microRNAs in vivo with “antagomirs”. Nature 438:685–689
65. Stenvang J, Petri A, Lindow M et al (2012) Inhibition of microRNA function by antimiR oligonucleotides. Silence 3:1
66. Petersen M, Bondensgaard K, Wengel J et al (2002) Locked nucleic acid (LNA) recognition of RNA: NMR solution structures of LNA:RNA hybrids. J Am Chem Soc 124:5974–5982
67. Nielsen KE, Rasmussen J, Kumar R et al (2004) NMR studies of fully modified locked nucleic acid (LNA) hybrids: solution structure of an LNA: RNA hybrid and characterization of an LNA:DNA hybrid. Bioconjug Chem 15: 449–457
68. Santaris.com [Home page in the internet]. Available from: http://www.santaris.com
69. Pencheva N, Tran H, Buss C et al (2012) Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell 151: 1068–1082
70. Obad S, dos Santos CO, Petri A et al (2011) Silencing of microRNA families by seedtargeting tiny LNAs. Nat Genet 43:371–378
71. Ebert MS, Neilson JR, Sharp PA et al (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4:721–726
72. Gentner B, Schira G, Giustacchini A (2009) Stable knockdown of microRNA in vivo by lentiviral vectors. Nat Methods 6:63–66
73. Zhang Y, Yang P, Sun T et al (2013) miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol 15:284–294
74. Ma L, Young J, Prabhala H et al (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12:247–256
75. Choi WY, Giraldez AJ, Schier AF (2007) Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science 318:271–274
76. Wang Z (2011) The principles of MiRNAmasking antisense oligonucleotides technology. Methods Mol Biol 676:43–49
77. Gumireddy K, Young DD, Xiong X et al (2008) Small-molecule inhibitors of microrna miR-21 function. Angew Chem Int Ed Engl 47:7482–7484
78. Melo S, Villanueva A, Moutinho C et al (2011) Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A 108: 4394–4399
79. Chiosea S, Jelezcova E, Chandran U et al (2006) Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am J Pathol 169:1812–1820
80. Takeshita F, Patrawala L, Osaki M et al (2010) Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell- cycle genes. Mol Ther 18:181–187
81. Cha ST, Chen PS, Johansson G et al (2012) MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis. Cancer Res 70:2675–2685
82. He Q, Zhou X, Li S et al (2013) MicroRNA- 181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPKSnai2 pathway. Biochim Biophys Acta 1830: 5258–5266
83. Kim SJ, Oh JS, Shin JY et al (2011) Development of microRNA-145 for therapeutic application in breast cancer. J Control Release 155:427–434
84. Hurst DR, Edmonds MD, Welch DR (2009) Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res 69: 7495–7498
85. Creighton CJ, Nagaraja AK, Hanash SM et al (2008) A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions. RNA 14:2290–2296
86. Yang Y, Chaerkady R, Beer MA et al (2009) Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach. Proteomics 9:1374–1384
87. Xiang X, Zhuang X, Ju S et al (2011) miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT. Oncogene 30:3440–3453
88. Korpal M, Ell BJ, Buffa FM et al (2011) Direct targeting of Sec23a by miR-200 s influences cancer cell secretome and promotes metastatic colonization. Nat Med 17:1101–1108
89. Gao D, Vahdat LT, Wong S et al (2012) Microenvironmental regulation of epithelialmesenchymal transitions in cancer. Cancer Res 72:4883–4889
90. Pantel K, Brakenhoff RH, Brandt B (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8:329–340
91. Pirollo KF, Zon G, Rait A et al (2006) Tumortargeting nanoimmunoliposome complex for short interfering RNA delivery. Hum Gene Ther 17:117–124
92. McNamara JO II, Andrechek ER, Wang Y et al (2006) Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol 24:1005–1015